Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_assertion type Assertion NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_head.
- NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_assertion description "[VDR TaqI polymorphism is associated with a group of men with benign prostatic hyperplasia who are at an increased risk of prostate cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_provenance.
- NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_assertion evidence source_evidence_literature NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_provenance.
- NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_assertion SIO_000772 15083213 NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_provenance.
- NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_assertion wasDerivedFrom lhgdn-20090331 NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_provenance.
- NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_assertion wasGeneratedBy ECO_0000203 NP204562.RA2l2Hhr-9zcsYsjFlcUod075pJRZQF7lS6FpVszfVH38130_provenance.